SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q3 2025
Institutional positions in SAB Biotherapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +9 vs. Q2 2025
- Shares held
- 28.0M
- +26.1M (+1,356.6%) vs. Q2 2025
- Total value
- $56.3M
- +$53.0M (+1,571.7%) vs. Q2 2025
- New holders
- 13
- 9 more added
- Sold out
- 4
- 2 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 11,420,000 | $23.0M | 1.85% | +11,420,000 | New |
| Ra Capital Management, L.P. | 4,401,500 | $8.85M | 0.11% | +4,401,500 | New |
| Commodore Capital LP | 4,401,500 | $8.85M | 0.43% | +4,401,500 | New |
| Woodline Partners LP | 2,850,881 | $5.73M | 0.03% | +2,850,881 | New |
| Sessa Capital IM, L.P. | 2,198,457 | $4.42M | 0.11% | +1,740,000+379.5% | Added |
| BVF Inc | 932,697 | $1.87M | 0.08% | +14,871+1.6% | Added |
| Sphera Funds Management Ltd. | 566,395 | $1.14M | 0.27% | +566,395 | New |
| Vanguard Group Inc | 365,753 | $735.2K | 0.00% | +83,382+29.5% | Added |
| HB Wealth Management, LLC | 307,500 | $618.1K | 0.00% | +307,500 | New |
| AWM Investment Company, Inc. | 200,000 | $402.0K | 0.04% | +200,000 | New |
| Geode Capital Management, LLC | 85,718 | $172.3K | 0.00% | +946+1.1% | Added |
| Renaissance Technologies LLC | 80,840 | $162.5K | 0.00% | +69,810+632.9% | Added |
| Pathstone Holdings, LLC | 50,650 | $101.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,982 | $40.0K | 0.00% | +19,982 | New |
| Kovitz Investment Group Partners, LLC | 19,201 | $38.6K | 0.00% | 00.0% | Unchanged |
| First PREMIER Bank | 18,986 | $38.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,781 | $31.7K | 0.00% | +15,781 | New |
| ADAR1 Capital Management, LLC | 15,000 | $30.1K | 0.00% | +15,000 | New |
| UBS Group AG | 13,221 | $26.6K | 0.00% | +2,563+24.0% | Added |
| Kestra Advisory Services, LLC | 11,930 | $24.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,387 | $22.9K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 11,221 | $22.6K | 0.00% | +11,221 | New |
| Caxton Corp | 10,935 | $22.0K | 0.10% | +10,935 | New |
| BlackRock, Inc. | 6,339 | $12.7K | 0.00% | −667−9.5% | Reduced |
| Advisor Group Holdings, Inc. | 4,824 | $9.99K | 0.00% | −113−2.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,560 | $3.14K | 0.00% | +834+114.9% | Added |
| Citigroup Inc | 832 | $1.67K | 0.00% | +832 | New |
| MAI Capital Management | 217 | $437 | 0.00% | 00.0% | Unchanged |
| Gs Investments, Inc. | 200 | $402 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 168 | $338 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 87 | $175 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 74 | $149 | 0.00% | +1+1.4% | Added |
| SBI Securities Co., Ltd. | 52 | $105 | 0.00% | +2+4.0% | Added |
| Harbour Investments, Inc. | 50 | $101 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,095−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −11,852−100.0% | Sold out |
| Sachetta, LLC | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −45−100.0% | Sold out |